| Element List | Explanation |
|---|---|
| Announcement Detail | Saudi Chemical Company Holding (SCCH) and Eli Lilly on December 27, 2021 signed an acquisition agreement, whereby SCCH will acquire all prescription rights of Cialis (5mg and 20mg) in the Kingdom of Saudi Arabia. It is to be noted that the completion of the transaction is conditional on the approval of relevant government bodies. |
Cialis is used to treat men with erectile dysfunction and also used to treat the signs and symptoms of benign prostatic hyperplasia (enlarged prostate gland that is not cancerous); and through this acquisition, AJA Pharmaceutical Industries (AJA Pharma), a subsidiary of (SCCH), would become the manufacturer and supplier for Cialis in the Saudi market. Cialis annual revenues in Saudi Arabia expected to reach around SAR 100 Mn (USD 26.7 Mn).
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.